Navigation Links
New Pleio Medication Adherence Service Increases Prescription Refills Up To 53%

Pleio GoodStart(tm) improves compliance and persistence with chronic medications. Prescription refills increase up to 53% during patients' first 100 days of therapy. New free service offers coaching, reminders and pharmacist support to alleviate stress and confusion some patients experience while adopting a newly - prescribed medication.

Philadelphia, PA (PRWEB) April 28, 2009 -- Pleio Health Support Systems, Inc. (Pleio) announces early results of Pleio GoodStart™, the free medication adherence service. Prescription refill data revealed that Pleio's combination of customized medication reminders, phone-based coaching sessions and pharmacist counseling improves prescription refill activity by up to 53%. Data shows a 14% increase in the first prescription refilled, building to a 53% improvement by the third refill. Refill behavior data from 2,850 patients was compiled and analyzed by Pleio.

"For many people, adapting to a new prescription can be stressful and confusing. Adherence to medication is a process that takes time - and patients welcome the 100 days of free support that Pleio provides. The 53% Rx refill improvement suggests that Pleio's sustained, customized patient adherence support works. The medication adherence community will welcome these real-world results," said Jean Lalonde, Co-Chief Executive Officer of Pleio.

Pleio GoodStart connects patients with specially-trained pharmacists via the Outcomes Pharmaceutical Health Care® Personal Pharmacist Network. "Pleio GoodStart supports pharmacists in delivering greater value to their patients while improving medication outcomes," said Patty Kumbera, Chief Operating Officer of Outcomes Pharmaceutical Health Care. The service is now available to over 20,000 pharmacies in the Outcomes Personal Pharmacist Network.

About Pleio:
Pleio Health Supports Systems, founded in 2006, has offices in Montreal and Boston. Pleio GoodStart is a sponsored and free adherence service that improves prescription refills by up to 53%. Pleio GoodStart™ is a registered trademark of Pleio Health Support Systems, Inc. For more information, visit Pleio or contact Jean Lalonde, at (514) 369-9995 (info (at)pleio (dot) com).

About Outcomes Pharmaceutical Health Care:
Outcomes Pharmaceutical Health Care is the national leader in the design, delivery, and administration of Medication Therapy Management programs. The company's service line benefits health care purchasers by delivering a cost effective approach to advancing patient care and controlling utilization through the provision of patient-friendly, face-to-face personal pharmacist services. The company is headquartered in Des Moines, Iowa and may be found online at Outcomes.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Drug Interaction Tool Offered Free in Response to Increasing At-Home Deaths From Medication Errors
2. Family Medicine Cabinet: Free, New On-Line Tool Helps Track Your Medication Safety
3. Cephalon Launches National Consumer Awareness Initiative on Appropriate Use of Prescription Opioid Medications
4. North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes
5. Prominent Physician Achieves Success Using Topical Sinus Medications via Pulsitile Irrigation
6. Pharmacy Students Taught Improved Medication Adherence and Holistic Health Services Through Program Incorporating InforMedixs Med-eXpert(TM) System
7. InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions
8. Artromick Aligns with McKesson to Enhance Medication Safety at the Patients Bedside
9. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
10. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)
11. FDA Approves Administration of LEXIVA(R) with Lower Dose of Boosting Medication Ritonavir
Post Your Comments:
(Date:10/13/2015)... , Oct. 13 2015 Research and ... "US & Europe Markets for Bone Morphogenetic Protein ... to their offering. --> ... that induce the formation of bone after a fracture. ... embryonic development in the formation of the skeleton. There ...
(Date:10/13/2015)... New York , October 13, 2015 ... Growth, Trends, and Forecast 2015 - 2023 " , ... in 2014 and is anticipated to reach US$7.59 bn by 2023, ... 2015 to 2023. --> " Microbiology Culture Market ... - 2023 " , the global microbiology culture ...
(Date:10/13/2015)... ... October 13, 2015 , ... AxioMx Inc. , a ... received a Phase I Small Business Innovative Research (SBIR) grant (1R43GM112204-01A1). This Phase ... Sciences (NIGMS), will fund the development of a technique to rapidly convert single-chain ...
(Date:10/13/2015)... YORK , October 13, 2015 ... acceleration and development company, has entered into a strategic ... York and Paris, France ... --> --> This collaborative arrangement ... highly respected scientific advisory team as well as long ...
Breaking Biology Technology:
(Date:10/12/2015)... , Oct. 9, 2015 Research and Markets ... Research, Inc,s new report "Biometrics: Market Shares, Strategies, ... --> --> The ... the Biometrics market segment. Research represents a selection from ... and cogent market materials, with selections made by the ...
(Date:10/12/2015)... -- Research and Markets ( ) has ... Market by Component (Hardware & Software), Product (Scanner ... (Travel & Immigration, Military & Defense, & Others) ... report to their offering. ... worth 3627.90 Million USD by 2020 ...
(Date:10/8/2015)... Oktober 2015 Die Track Group, ... des Bereiches Tracking, hat heute bekannt gegeben, ... Virginias (Department of Corrections – DOC) unterzeichnet ... alle Strafen geliefert werden, die der Behörde ... für den Amerikanischen Kontinent der Track Group. ...
Breaking Biology News(10 mins):